\"
28-29 November 2017 |
Vienna, Austria

Media Center

Video

Serialisation, Track & Trace and e-Pedigree for Pharma

Sebastien Mauel, Head of Product Security, Merck Serono, shares his insights with Pharma IQ at IQPC's Pharmaceutical Serialisation & Traceability event. Mauel discusses the current challenges relating to detecting counterfeit drugs in the supply chain, preventing counterfeiting at the pharmacy, strategies for successful authentication of pharmaceutical products and the benefits and pitfalls of the e-pedigree approach.

Serialisation, Traceability and Coding – Responding as a Pharmaceutical Company to the Challenges

In this presentation Christoph Krähenbühl, IS Programme Manager, Pack Coding and Product Security, AstraZeneca discusses product security, patient safety, anti-counterfeiting, supply chain control and coding. He also discussed how AstraZeneca tackles some of these issues.

PDF

Traceability in Operation Market Research: Concerns and Priorities

Ahead of the Traceability In Operation forum 2017 Pharma IQ conducted some market research to pinpoint the concerns and priorities of those in the more mature phases of serialisation. Commentary supplied by Pasi Kemppainen, Executive Consultant, Pharma Serialization and Traceability.

Exclusive: Interview On GS1’s Traceability Guideline for Brazil

After around six months of consultation, global standards organisation GS1 is in the final stages of compiling its Brazilian Medicine Traceability using GS1 EPCIS Part 1 Implementation Guide.

In the lead up to this hotly anticipated document, Pharma IQ spoke to Eduardo Salles, Director da Dotter do Brazil who assisted with the creation of this GS1 file.

Industry Report: Global Traceability and Serialisation Pharma


In this Serialisation Report, Pharma IQ presents the findings of its latest industry survey while drawing trends on previous years to explore the shifts in industry consensus. Plus, Pharma IQ presents its printable Serialisation Deadline Worldmap.

10 Tips for Developing a Serialisation Strategy: Your Roadmap to Success!

The serialisation strategy of a company and the resultant serialisation service that delivers and maintains the capabilities required, needs to ensure that the requirements of legislation are understood and the capabilities are defined to meet those needs. Once serialisation capabilities become available, companies can then look to leverage them for product security and other benefits that are not directly driven by legislation. Pharma IQ presents a series of 10 tips for developing and implementing your serialisation strategy.

Articles

A One Page Guide to Drug Supply Chain Security Act (DSCSA)

Pharma IQ presents this interactive one page guide to the Drug Supply Chain Security Act (DSCSA) Implementation Plan

Pharmaceutical Serialization & Traceability 2017 Market Research

The end of 2017 is peppered with compliance deadlines for the track and trace industry as it joins the combat against counterfeit pharmaceuticals. These regions include the likes of Canada, the US and Ukraine. Despite the urgency, many medicine manufacturers in the industry have been labelled as behind schedule. With time running low, take a look at Pharma IQ’s 2017 serialization research and benchmark where you sit in the race. Shortly we will be releasing indepth analysis on these findings with help from industry experts.

Managing Serialisation – Authentication and Track and Trace

In this article we will discuss publishing the related serialisation information and two of the common serialisation models, Authentication and Track and Trace. Product Information Notification Typically, once product packaging of one or more levels has been uniquely identified, this information, together with other information related to the product and manufacturer is passed to an external agency database. 

Tackling the Challenge of Serialisation and Traceability

As counterfeit drug sales become increasingly costly to both pharmaceutical manufacturers and patients, companies are attempting to address the challenges of serialisation and traceability to reduce the burden on health services across the world.

Drug Quality and Security Act- New US Legislation for Pharma Tracking

Don’t be distracted by news of a ‘shutdown’ in the American government, some of the biggest news from the pharmaceutical legislation perspective is not related to the inability to pass a budget. The Drug Quality and Security Act will have a bigger impact on pharma.

Podcasts

Pharmaceutical Serialisation - The Global Problem with No Global Solution

In this Pharma IQ interview Pasi Kemppainen, executive consultant for serialisation and traceability and current lead of serialisation implementation at Orion Pharma, shares his insights on why the pharmaceutical industry has been slow to adopt mass serialisation, key implementation challenges and preparing for regulation requirements in the future.

Pasi Kemppainen on Managing & Implementing Pharmaceutical Serialisation

Pasi Kemppainen is an executive consultant for serialisation and traceability and currently leading the serialisation implementation at Orion Pharma. In this interview he speaks to Andrea Charles from Pharma IQ, about managing and implementing serialisation and shares his top tip for preparing  for regulation requirements and implementation in the future.